Our Technology
Our Platform
Our modular platform unlocks infinite in vivo cell & gene therapy product opportunities
CELLfinity™ Platform
TQx is developing a modular target cell-specific modification platform for the generation of infinite in vivo cell & gene therapy product opportunities
Drug Delivery System
Automated drug delivery application system
The CELLbricator system enables our CELLbricate™ PRO & CELLbricate™ ULTRA process. The system combines highly automated targeted cell selection and genetic manipulation within one step. The T-FABfinity™ technology is an integrated component of our system enabling safe and selective in vivo therapy delivery
Cell Selection (T-FABfinity™)
TQ Therapeutics’ proprietary T-FABfinity™ cell selection technology, an affinity and column-based cell isolation technology is a closed, automated module for fast, residual-free positive cell selection of untouched CD3+ T target cells from sources such as whole blood and apheresis products. The module will deliver high-purity cell enrichment in under two hours, streamlining workflows.
Marker Library: We can extend our cell selection markers to any cell type that is expressing an antigen on their surface (e.g. NK cells, B-Cells…)
Cell Activation (FABtivate™)
The FABtivate™ activation reagent is a soluble, three-component protein complex composed of a multimerized Streptactin backbone functionalized with kinetically optimized anti-CD3 and anti-CD28 Fab fragments. Designed for in vitro stimulation and expansion of human T cells, FABtivate™ is particularly optimized for automated cell manufacturing systems.
It delivers robust, physiological T cell activation with precise control over stimulation (strength and duration). The activation signal can be rapidly and completely terminated by administering D-Biotin, which triggers dissociation of the complex and enables full removal of FABtivate™ residuals during downstream processing. FABtivate™ is seamlessly integratable in our CELLbricate™ PRO Process.
You might be interested in
Get in touch!
If you are interested in our technology or platform, feel free to reach out!
TQ Therapeutics GmbH
Fraunhoferstr. 1
82152 Planegg Germany
Phone: +49 89 / 248 870 4 - 50
Email: info@tqtherapeutics.com